peptual bpc-157 VIAL - High-Purity Peptide for Research BPC-157/NAD+/GUK-Cu - Peptide Patch -

Smart N, et al

Canadian buyers should prioritize suppliers offering: Third-party testing with publicly available results Certificates of Analysis including HPLC-MS data Endotoxin testing results below accepted thresholds Proper storage and shipping (cold chain maintenance) Established reputation in peptide research communities Domestic Canadian suppliers offer advantages including faster shipping (typically 2-4 business days), CAD pricing without exchange rate concerns, and simplified customs processes compared to international orders

However, because this was a retrospective observational study, the findings cannot establish that higher semaglutide doses directly caused the improved cardiovascular outcomes, and unmeasured confounding factors may have influenced the observed associations

And in April 2026, after almost three years of regulatory limbo, the US Food and Drug Administration removed BPC-157 from its list of bulk drug substances flagged for significant safety concerns